Long-term follow-up after bioresorbable vascular scaffold implantation in STEMI patients: PRAGUE-19 study update

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61383082%3A_____%2F16%3A00000204" target="_blank" >RIV/61383082:_____/16:00000204 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216224:14110/16:00090040 RIV/00216208:11110/16:10327350 RIV/00216208:11120/16:43911608 RIV/00064173:_____/16:N0000047

Výsledek na webu

<a href="https://www.pcronline.com/eurointervention/98th_issue/volume-12/number-1/05/long-term-follow-up-after-bioresorbable-vascular-scaffold-implantation-in-stemi-patients-prague-19-study-update.html" target="_blank" >https://www.pcronline.com/eurointervention/98th_issue/volume-12/number-1/05/long-term-follow-up-after-bioresorbable-vascular-scaffold-implantation-in-stemi-patients-prague-19-study-update.html</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.4244/EIJV12I1A5" target="_blank" >10.4244/EIJV12I1A5</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Long-term follow-up after bioresorbable vascular scaffold implantation in STEMI patients: PRAGUE-19 study update

Popis výsledku v původním jazyce

Aims: Early clinical results after implantation of bioresorbable vascular scaffolds (BVS) in ST-elevation myocardial infarction (STEMI) are encouraging, but long-term data are missing. This study evaluates long-term outcome in STEMI patients with implanted BVS. Methods and results: The PRAGUE-19 study is an academic study enrolling consecutive STEMI patients with the intention to implant BVS. A total of 580 STEMI patients were screened between December 2012 and March 2015; 117 patients fulfilled entry criteria and BVS was successfully implanted in 114 (97%) of them. The primary combined clinical endpoint (death, reinfarction or target vessel revascularisation) occurred in 11.5% during the mean follow-up period of 730 +/- 275 days with overall mortality of 4.4%. Definite scaffold thrombosis occurred in two patients in the early phase after BVS implantation; there was no late thrombosis. Quantitative coronary angiography (10 patients) at three years demonstrated late lumen loss of 0.2 +/- 0.33 mm and optical coherence tomography showed minimal lumen area of 5.3 +/- 1.37 mine and neointimal hyperplasia area of 2.9 +/- 0.48 mm(2). BVS struts were still visible at three years and 99.4% of them were well apposed and covered. Conclusions: Encouraging clinical and imaging results after BVS implantation in STEMI patients persist during long-term follow-up.

Název v anglickém jazyce

Long-term follow-up after bioresorbable vascular scaffold implantation in STEMI patients: PRAGUE-19 study update

Popis výsledku anglicky

Aims: Early clinical results after implantation of bioresorbable vascular scaffolds (BVS) in ST-elevation myocardial infarction (STEMI) are encouraging, but long-term data are missing. This study evaluates long-term outcome in STEMI patients with implanted BVS. Methods and results: The PRAGUE-19 study is an academic study enrolling consecutive STEMI patients with the intention to implant BVS. A total of 580 STEMI patients were screened between December 2012 and March 2015; 117 patients fulfilled entry criteria and BVS was successfully implanted in 114 (97%) of them. The primary combined clinical endpoint (death, reinfarction or target vessel revascularisation) occurred in 11.5% during the mean follow-up period of 730 +/- 275 days with overall mortality of 4.4%. Definite scaffold thrombosis occurred in two patients in the early phase after BVS implantation; there was no late thrombosis. Quantitative coronary angiography (10 patients) at three years demonstrated late lumen loss of 0.2 +/- 0.33 mm and optical coherence tomography showed minimal lumen area of 5.3 +/- 1.37 mine and neointimal hyperplasia area of 2.9 +/- 0.48 mm(2). BVS struts were still visible at three years and 99.4% of them were well apposed and covered. Conclusions: Encouraging clinical and imaging results after BVS implantation in STEMI patients persist during long-term follow-up.

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FE - Ostatní obory vnitřního lékařství

OECD FORD obor

—

Projekt

—

Návaznosti

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Rok uplatnění

2016

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

EUROINTERVENTION

ISSN

1774-024X

e-ISSN

—

Svazek periodika

12

Číslo periodika v rámci svazku

1

Stát vydavatele periodika

FR - Francouzská republika

Počet stran výsledku

7

Strana od-do

23-29

Kód UT WoS článku

000379196400006

EID výsledku v databázi Scopus

—